Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

47.41
Delayed Data
As of Aug 23
 -0.08 / -0.17%
Today’s Change
45.80
Today|||52-Week Range
59.00
-18.37%
Year-to-Date
Better Buy: AbbVie Inc. vs. Eli Lilly & Co.
Aug 17 / MotleyFool.com - Paid Partner Content
Top 3 Research Reports for August 12, 2016
Aug 12 / Zacks.com - Paid Partner Content
Novo Nordisk A/S Focuses on New Drugs
Aug 16 / MotleyFool.com - Paid Partner Content
Novo Nordisk (NVO) Beats Q2 Earnings, Revenues Up Y/Y
Aug 08 / Zacks.com - Paid Partner Content
3 Beaten-Up Big Pharma Stocks: Are They Bargains?
Aug 14 / MotleyFool.com - Paid Partner Content